Tiziana Life Sciences Ltd TLSA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 3.22% | 0.00% | -127.25% | 0.00% |
| Total Depreciation and Amortization | 0.00% | 8.22% | 0.00% | 65.91% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | 36.18% | 0.00% | 348.68% | 0.00% |
| Change in Net Operating Assets | 0.00% | -51.13% | 0.00% | 380.54% | 0.00% |
| Cash from Operations | 0.00% | -22.11% | 0.00% | 11.71% | 0.00% |
| Capital Expenditure | 0.00% | -300.00% | 0.00% | -150.00% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00% | -93.83% | 0.00% |
| Cash from Investing | 0.00% | -136.81% | 0.00% | -94.34% | 0.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 12.16% | 0.00% | -208.33% | 0.00% |
| Issuance of Common Stock | 0.00% | 141.84% | 0.00% | -62.93% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00% | -- | -- |
| Cash from Financing | 0.00% | 146.07% | 0.00% | -64.05% | 0.00% |
| Foreign Exchange rate Adjustments | 0.00% | 380.77% | 0.00% | -123.64% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 74.33% | 0.00% | -191.89% | 0.00% |